Sterility of non-preservative eye drops

Journal of the Medical Association of Thailand

Volumn 88, Issue SUPPL. 9, 2005, Pages

  Prabhasawat, Pinnita ^a   Chotikavanich, Suksri ^a   Leelaporn, Amornrut ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Autologous serum; Fortified antibiotics; Non preservative steroid; Non preservative topical eye drop; Sterility

Indexed keywords

AMIKACIN; CEFAZOLIN; DEXAMETHASONE; DRUG PRESERVATIVE; EYE DROPS; GENTAMICIN; METHYLPREDNISOLONE; THIOGLYCOLIC ACID; VANCOMYCIN;

ARTICLE; BACTERIUM CONTAMINATION; CELL CULTURE; DRUG CONTAMINATION; DRUG SAFETY; DRUG STERILITY; DRUG STORAGE; DRUG USE; HOSPITAL PATIENT; MICROBIAL CONTAMINATION; RISK ASSESSMENT; SERUM;

ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG CONTAMINATION; DRUG TOXICITY; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STEROIDS;

EID: 31544436613     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rajpal RK, Glaser SR. Antiseptics and Disinfectants. In: Kooner KS, Sharir M, editors. Textbook of Pharmacology. Philadelphia: Lipppincott-Raven, 1997: 662-3.
2. Reilly CD, Mannis MJ, Chang SD. Toxic conjunctivitis. In: Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. Philadelphia: Elsevier Mosby, 2005: 703-11.
3. Tuli S, Goldstein M, Schultz GS. Modulation of corneal wound healing. In: Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. Philadelphia: Elsevier Mosby, 2005: 133-50.
4. Baudouin C, Gaarcher C, Haouat N, Bron A, Gastaud P. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 1994; 101: 454-60.
5. De Saint JM, Brignol F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999; 40: 619-30.
6. Baudouin C, Pouliquen PJ, Fillacier K, Goldschild M, Becquet F, De Saint JM, et al. Ocular surface inflammatory changes induced by topical anti-glaucoma drugs: human and animal studies. Ophthalmology 1999; 106: 556-63.
7. Pisella P, Pouliquen JP, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002; 86: 418-23.
8. Djalilian AR, Hamrah P, Pflugfelder SC. Dry eye. In: Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. Philadelphia: Mosby, 2005: 534-5.
9. Ichijima H, Pretrol WM, Jester JV, Cavanaugh HD. Confocal micropic studies of living rabbit cornea treated with benzalkonium chloride. Cornea 1992; 11: 221-5.
10. Brilakis HS, Palmon FE, Webster GF, Holland EJ. Erythema multiforme, Stevens-Johnson syn-drome, and toxic epidermal necrolysis. In: Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. Philadelphia: Mosby, 2005: 697-8.
11. Adams J, Wilcox MJ, Trousdale MD, Chien DS, Shimizu RW. Morphorogic and physioligic effects of artificial tear formulations on corneal epithelial derived cells. Cornea 1992; 11: 234-41.
12. Arici MK, Sumer Z, Guler C, Elibol O, Saygi G, Cetinkaya S. In vitro potency and stability of fortified ophthalmic antibiotics. Aust N Z J Ophthalmol 1999; 27: 426-30.
13. Tananuvat N, Daniell M, Sullivan LJ, Yi Q, Mckelvi P, Mccarty DJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001; 20: 802-6.
14. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999; 83: 390-5.
15. Noble BA, Loh RS, Maclennan S, Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2 004; 88: 647-52.
16. Kulakarni PS. Steroids in ocular therapy. In: Kooner KS, Sharir M, editors. Textbook of ocular pharmacology. Philadelphia: Lippincott-Raven, 1997: 64.
17. Prabhasawat P, Tseng SCG. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol 1998; 82: 666-75.
18. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999; 106: 811-6.
19. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984-9.